EGFR and nasopharyngeal carcinoma: Meanwhile, as EGFR has been reported as an important regulator of VM in various malignancies30,31, we considered that VM may be the main leading cause that is associated with the difference in efficacy of anti-angiogenic drugs and anti-EGFR drugs in nasopharyngeal carcinoma.